SARG contributes to major new report on e-cigarettes

The Sheffield Addictions Research Group has contributed to a major new report on e-cigarettes from the Royal College of Physicians.
The report, 'E-cigarettes and harm reduction: An evidence review', explores several themes including how e-cigarettes can be used to support more people to make quit attempts while discouraging young people and never-smokers from taking up e-cigarettes.
SARG team members Alan Brennan, Duncan Gillespie, Damon Morris and Luke Wilson reviewed current models to assess the cost-effectiveness of using e-cigarettes for smoking cessation (section 4.7) and looked in depth at potential pricing policy options for e-cigarettes including for example reducing VAT on e-cigarette devices, introducing excise tax on disposable vapes and subsidising e-cigarettes for people accessing stop smoking support (section 6.3).
Their work contributes to wider debates about health and economic considerations around e-cigarette use and demonstrates how modelling can play an important role in understanding the benefits and drawbacks of different approaches.
This is the third report by the Royal College of Physicians that the Sheffield Addictions Research Group has been involved with. In 2018 we contributed to 'Hiding in plain sight: Treating tobacco dependency in the NHS' while in 2021 we provided content for 'Smoking and health 2021: A coming of age for tobacco control?'
Tobacco research at the University of Sheffield
The report comes during a period of rapid growth in tobacco research at the University of Sheffield.
We are collaborating with colleagues at University College London on a major project funded by Cancer Research UK to develop new detailed modelling of tobacco smoking and quitting behaviour, participating in a new 'Health Hub' consortium in which we will develop models of regional tobacco policy alongside other commercial determinants of health, and are developing bids to model new e-cigarette policy.
We are also evaluating new smoking cessation services in hospitals, funded by Yorkshire Cancer Research, and the government's 'Swap to Stop' e-cigarette scheme, as part of the Department of Health and Social Care's Policy Research Unit in Addictions.
Our modelling work was also instrumental in the development of the Tobacco and Vapes Bill which aims to create a 'smoke-free generation' and reduce the number of smoking related deaths.
Further reading
SYNTAX – 'Integrated evidence synthesis for joint appraisal of tobacco and alcohol tax interventions for harm reduction in the UK'. This project provided evidence and tools to inform the potential scale of effects of taxation across tobacco and alcohol as an intervention to improve public health and reduce health inequalities in the UK.
STAPM – 'The Sheffield Alcohol and Tobacco Policy Modelling Platform'. The aim of the STAPM research programme is to identify and evaluate approaches to reducing the harm from tobacco and alcohol, with the aim of improving commissioning in a public health policy context.
Tobacco and new nicotine product pricing policy: past, present and future (February 2024) An overview of Duncan Gillespie's talk at a SPECTRUM Consortium event exploring the potential impact of various pricing strategies on tobacco use and public health.
-
New SARG report details alcohol-related health and financial burden in Northern Ireland
The Sheffield Addictions Research Group (SARG) has published new analysis estimating the substantial health and financial toll of alcohol consumption in Northern Ireland, using the most recent available post-pandemic data.
-
New report reveals further growth and key trends in alcohol-free and low-alcohol drinks market
A second Monitoring Report from the Sheffield Addictions Research Group has been published, revealing further growth in the alcohol-free and low-alcohol (no/lo) drinks market and offering new insights into consumer behaviour and pricing.
-
SARG researchers to present at European nicotine and tobacco conference
Two researchers from the Sheffield Addictions Research Group (SARG), Esther Moore and Professor Hazel Squires, will present their latest findings at the annual conference of the European Chapter of the Society for Research on Nicotine and Tobacco (SRNT-E).
-
SARG researcher secures major Wellcome funding to model how context influences alcohol consumption
Dr Amber Copeland from the Sheffield Addictions Research Group (SARG) has been awarded a prestigious Wellcome Trust fellowship worth £591,755 over five years. The funding will support a new project to develop a cutting-edge computational model that explores how a person's environment influences their attempts to cut down on alcohol.
You might also be interested in…
-
Spring Budget 2024: What does it mean for alcohol and e-cigarettes?
Following the Spring Budget on 6th March 2024, SARG experts Colin Angus and Duncan Gillespie take a look at what it means for alcohol and e-cigarette taxes.
-
SARG researchers present at UKPRP Conference
Dr Damon Morris and Dr Duncan Gillespie recently attended the Prevention Research Conference and the SPECTRUM Consortium Annual Meeting in Edinburgh.
-
QUIT Programme Evaluation
Yorkshire Cancer Research commissioned the Sheffield Centre for Health and Related Research (SCHARR) at the University of Sheffield to carry out a comprehensive evaluation of hospital-based stop smoking services in the region, starting with the Quit programme.